Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate

Author: Benzinga Newsdesk | August 07, 2024 04:26pm
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 44.83 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $7.858 million which beat the analyst consensus estimate of $7.330 million by 7.21 percent. This is a 32.07 percent increase over sales of $5.950 million the same period last year.

Posted In: CLPT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist